Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.

Research output: Contribution to journalArticle

Abstract

Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 ("high-intensity" warfarin).

Original languageEnglish (US)
Pages (from-to)370-373
Number of pages4
JournalCurrent Rheumatology Reports
Volume5
Issue number5
StatePublished - Oct 2003

Fingerprint

Antiphospholipid Syndrome
Thrombosis
Clinical Trials
International Normalized Ratio
Warfarin

ASJC Scopus subject areas

  • Rheumatology

Cite this

Evidence-based management of thrombosis in the antiphospholipid antibody syndrome. / Petri, Michelle.

In: Current Rheumatology Reports, Vol. 5, No. 5, 10.2003, p. 370-373.

Research output: Contribution to journalArticle

@article{c988190e6f5c46bdb58a2bf82f83736a,
title = "Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.",
abstract = "Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 ({"}high-intensity{"} warfarin).",
author = "Michelle Petri",
year = "2003",
month = "10",
language = "English (US)",
volume = "5",
pages = "370--373",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.

AU - Petri, Michelle

PY - 2003/10

Y1 - 2003/10

N2 - Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 ("high-intensity" warfarin).

AB - Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 ("high-intensity" warfarin).

UR - http://www.scopus.com/inward/record.url?scp=0347571621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347571621&partnerID=8YFLogxK

M3 - Article

C2 - 12967519

AN - SCOPUS:0347571621

VL - 5

SP - 370

EP - 373

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 5

ER -